Shouyao Holdings (Beijing) Co Ltd Class A 688197
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ¥31.96
- Day Range
- ¥32.03–34.18
- 52-Week Range
- ¥26.81–61.63
- Bid/Ask
- ¥34.10 / ¥34.11
- Market Cap
- ¥5.07 Bil
- Volume/Avg
- 614,829 / 444,378
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1,262.16
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Shouyao Holdings (Beijing) Co Ltd is engaged in the research and development and production of innovative drugs.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 185
- Website
- http://www.shouyaoholding.com
Comparables
Valuation
|
Metric
|
688197
|
688739
|
300149
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 28.96 | — |
Price/Book Value | 5.53 | 1.12 | 2.17 |
Price/Sales | 1,262.16 | 6.00 | 2.76 |
Price/Cash Flow | — | 16.98 | 22.49 |
Price/Earnings
688197
688739
300149
Financial Strength
|
Metric
|
688197
|
688739
|
300149
|
|---|---|---|---|
Quick Ratio | 5.01 | 17.26 | 1.46 |
Current Ratio | 7.48 | 18.49 | 1.71 |
Interest Coverage | −1,925.03 | 288.58 | −32.05 |
Quick Ratio
688197
688739
300149
Profitability
|
Metric
|
688197
|
688739
|
300149
|
|---|---|---|---|
Return on Assets (Normalized) | −19.22% | 3.14% | −34.73% |
Return on Equity (Normalized) | −21.07% | 3.29% | −54.47% |
Return on Invested Capital (Normalized) | −22.11% | 2.81% | −38.80% |
Return on Assets
688197
688739
300149
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Glrsjzpbrq | Ktwt | $554.5 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Dnrxzpsz | Qgvxd | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Znzlyjxz | Txgcvfw | $114.6 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Jbbzhztl | Qywttc | $35.2 Bil | |||
| argenx SE ADR
ARGX
| Lykxbvrzh | Kvnk | $31.7 Bil | |||
| BioNTech SE ADR
BNTX
| Shdvrfzj | Rnx | $28.0 Bil | |||
| Moderna Inc
MRNA
| Cndsklvjg | Hqkpv | $24.6 Bil | |||
| United Therapeutics Corp
UTHR
| Bnljsrvxh | Xytz | $15.9 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Ykwkrcyg | Vdcknm | $13.4 Bil | |||
| Royalty Pharma PLC Class A
RPRX
| Xvfkmfdhvp | Nvgnw | $12.6 Bil |
United States